Moderna, Inc. (MRNA) Total liabilities 2017–2025
Moderna, Inc. (MRNA) total liabilities at each fiscal year-end, per SEC filings.
$3.7BFY2025 · since FY2017: $459.2M → $3.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7B | +13.8% |
| FY2024 | $3.2B | -29.1% |
| FY2023 | $4.6B | -32.1% |
| FY2022 | $6.7B | -36.0% |
| FY2021 | $10.5B | +120.4% |
| FY2020 | $4.8B | +1051.9% |
| FY2019 | $414.6M | -4.0% |
| FY2018 | $431.9M | -5.9% |
| FY2017 | $459.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice